Activating mutations of the G(s)α gene are associated with low levels of Gsα protein in growth hormone-secreting tumors

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 12, 1998, Pages 4386-4390

  Ballaré, Emilia ^c   Mantovani, Simona ^c   Lania, Andrea ^c   Di Blasio, Anna M ^a   Vallar, Lucia ^b   Spada, Anna ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c IRCCS ^*

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; CYCLIC AMP; GROWTH HORMONE; GUANINE NUCLEOTIDE BINDING PROTEIN; MUTANT PROTEIN; CHOLERA TOXIN; HUMAN GROWTH HORMONE; MESSENGER RNA;

ARTICLE; CLINICAL ARTICLE; ENZYME ACTIVATION; FEEDBACK SYSTEM; GENE ACTIVATION; GENE DELETION; GENE MUTATION; GENETIC ANALYSIS; GROWTH HORMONE RELEASE; HUMAN; HUMAN TISSUE; HYPOPHYSIS TUMOR; POINT MUTATION; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEIN SYNTHESIS REGULATION; ADENOMA; DRUG ANTAGONISM; GENE EXPRESSION REGULATION; GENETICS; IMMUNOBLOTTING; METABOLISM; MUTATION; PHYSIOLOGY; SECRETION;

ADENOMA; CHOLERA TOXIN; GENE EXPRESSION REGULATION; GTP-BINDING PROTEINS; HUMAN GROWTH HORMONE; HUMANS; IMMUNOBLOTTING; MUTATION; PITUITARY NEOPLASMS; RNA, MESSENGER;

EID: 0032252404     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.83.12.5354     Document Type: Article

References (29)

1. 1. Shimon I, Melmed S. 1997 Genetic basis of endocrine disease: pituitary tumor pathogenesis. J Clin Endocrinol Metab. 82:1675-1681.
2. s and stimulate adenylyl cyclase in human pituitary tumors. Nature. 340:692-696.
3. 3. Thakker RV, Pook MA, Wooding C, Boscaro M, Scanarini M, Clayton RN. 1993 Association of somatotrophinomas with loss of alleles on chromosome 11 and gsp mutations. J Clin Invest. 91:2815-2821.
4. 4. Zhuang Z, Ezzat SZ, Vortmejer AO, et al. 1997 Mutations of the MEN 1 tumor suppressor gene in pituitary tumors. Cancer Res. 57:5446-5451.
5. 5. Prezant TR, Levine J, Melmed S. 1998 Molecular characterization of the Men 1 tumor suppressor gene in sporadic pituitary tumors. J Clin Endocrinol Metab. 83:1388-1391.
6. 6. Billestrup N, Swanson LW, Vale W. 1986 Growth hormone releasing factor stimulates cell proliferation of somatotrophs in vitro. Proc Natl Acad Sci USA. 83:6854-6857.
7. 7. Lyons J, Landis CA, Harsh G, et al. 1990 Two G protein oncogenes in human endocrine tumors. Science. 249:655-659.
8. 8. O'Sullivan C, Barton CM, Staddon SL, Brown CL, Lemoine NR. 1991 Activating point mutations in the gsp oncogene in human thyroid adenomas. Mol Carcinogen. 4:345-349.
9. sp mutations in human thyroid tumours. Oncogene. 6:677-679.
10. 10. Dumont JE, Jauniaux JC, Roger PP. 1989 The cAMP-mediated stimulation of cell proliferation. Trends Biochem Sci. 14:67-71.
11. 11. Maenhaut C, Roger PP, Reuse S, Dumont JE. 1991 Activation of the cyclic AMP cascade as an oncogenic mechanism: the thyroid example. Biochimie. 73:29-36.
12. 12. Spada A, Vallar L, Faglia G. 1992 G protein oncogenes in pituitary tumors. Trends Endocrinol Metab. 3:355-360.
13. 13. Vallar L. 1996 Oncogenic role of heterotrimeric G proteins. Cancer Surv. 27:325-338.
14. sα enhances activation of the adenylyl cyclase signal transduction cascade. Mol Endocrinol. 11:1053-1061.
15. 15. Siperstein AE, Miller RA, Landis C, Bourne H, Clark OH. 1991 Increased stimulatory G protein in neoplastic human thyroid tissues. Surgery. 110:949-953.
16. sα gene. J Cancer Res Clin Oncol. 121:219-224.
17. sα protein-adenylate cyclase pathway may not be sufficient to generate toxic thyroid adenomas. J Clin Endocrinol Metab. 81:1898-1904.
18. 18. Bertherat J, Chanson P, Montminy M. 1995 The cyclic adenosine 3′,5′ monophosphate-responsive factor CREB is constitutively activated in human somatotroph adenomas. Mol Endocrinol. 9:777-783.
19. 19. Bassetti M, Spada A, Arosio M, Vallar L, Brina M, Giannattasio G. 1986 Morphological studies on mixed growth hormone (GH) and prolactin (PRL)-secreting adenomas. Coexistence of GH and PRL in the same secretory granules. J Clin Endocrinol Metab. 418:405-410.
20. sα is associated with an increased phosphodiesterase activity in human growth hormone-secreting adenomas. J Clin Endocrinol Metab. 83:1624-1628.
21. 21. Viganò P, Gaffuri B, Ragni G, Di Blasio AM, Vignali M. 1997 Intercellular adehesion molecule-1 is expressed on human granulosa cells and mediates their binding to lymphoid cells. J Clin Endocrinol Metab 82:101-105.
22. 22. Ballarè E, Mantovani S, Bassetti M, Lania A, Spada A. 1997 Immunodetection of G proteins in human pituitary adenomas; evidence for a low expression of proteins of the Gi subfamily. Eur J Endocrinol. 137:482-489.
23. 2+ in rat somatotrophs. Endocrinology. 122:1419-1425.
24. s and adenylate cyclase activity in human GH-secreting pituitary adenomas. Nature. 330:566-567.
25. 25. Adams EF, Brockmeier S, Friedmann E, Roth M, Buchfelder M, Fahlbusch R. 1993 Clinical and biochemical characteristics of acromegalic patients harboring gsp-positive and gsp-negative pituitary rumors. Neurosurgery. 33:198-203.
26. sα mutations in somatotroph adenomas. J Clin Endocrinol Metab. 83:1604-1610.
27. s. J Biol Chem. 264:5352-5357.
28. s in intact cells alters its abundance, rate of degradation and membrane avidity. J Cell Biol. 119:1297-1305.
29. 29. Spiegel AM. 1996 Mutations in G proteins and G protein-coupled receptors in endocrine disease. J Clin Endocrinol Metab. 81:2434-2442.